Primary Site >> Colorectal Cancer
Gene >> ADORA3
| 1. | |||||||||||
| Journal: | Br J Cancer. 2003 Oct 20;89(8):1552-8. | ||||||||||
| Title: | Inhibition of primary colon carcinoma growth and liver metastasis by the A3 adenosine receptor agonist CF101. | ||||||||||
| Author: | Ohana, G|Bar-Yehuda, S|Arich, A|Madi, L|Dreznick, Z|Rath-Wolfson, L|Silberman, D|Slosman, G|Fishman, P | ||||||||||
| PMID: | 14562031 | ||||||||||
| 2. | |||||||||||
| Journal: | Oncogene. 2004 Apr 1;23(14):2465-71. | ||||||||||
| Title: | An agonist to the A3 adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3 beta and NF-kappa B. | ||||||||||
| Author: | Fishman, Pnina|Bar-Yehuda, Sara|Ohana, Gil|Barer, Faina|Ochaion, Avivit|Erlanger, Abigail|Madi, Lea | ||||||||||
| PMID: | 14691449 | ||||||||||
| 3. | |||||||||||
| Journal: | Neoplasia. 2005 Jan;7(1):85-90. | ||||||||||
| Title: | CF101, an agonist to the A3 adenosine receptor, enhances the chemotherapeutic effect of 5-fluorouracil in a colon carcinoma murine model. | ||||||||||
| Author: | Bar-Yehuda, Sara|Madi, Lea|Silberman, Daniel|Gery, Slosman|Shkapenuk, Maya|Fishman, Pnina | ||||||||||
| PMID: | 15720820 | ||||||||||
| 4. | |||||||||||
| Journal: | Expert Opin Emerg Drugs. 2007 Sep;12(3):479-92. | ||||||||||
| Title: | Emerging adenosine receptor agonists. | ||||||||||
| Author: | Gao, Zhan-Guo|Jacobson, Kenneth A | ||||||||||
| PMID: | 17874974 | ||||||||||
| 5. | |||||||||||
| Journal: | Contrast Media Mol Imaging. 2018 Feb 13;2018:1269830. | ||||||||||
| Title: | Preclinical In Vitro and In Vivo Evaluation of [(18)F]FE@SUPPY for Cancer PET Imaging: Limitations of a Xenograft Model for Colorectal Cancer. | ||||||||||
| Author: | Balber, T|Singer, J|Berroteran-Infante, N|Dumanic, M|Fetty, L|Fazekas-Singer, J|Vraka, C|Nics, L|Bergmann, M|Pallitsch, K|Spreitzer, H|Wadsak, W|Hacker, M|Jensen-Jarolim, E|Viernstein, H|Mitterhauser, M | ||||||||||
| PMID: | 29666562 | ||||||||||